Summit Therapeutics plc (“Summit” or “Company”)
Summit announces its intention to redomide its U.S. comparison block
Oxford, United Kingdom and Cambridge, MA, USA, 16 July 2020 – Summit Therapeutics plc (NASDAQ: SMMT) today announced its intention to move its headquarters from the British company to the United States. The proposed redomiciliation is consistent with Summit’s growing interest in advertising operations in the U.S., and adds its plans to advertise ridinilazol for C. difficile infection therapy (“CDI”), if necessary. In addition, Summit expects to gain greater corporate flexibility and gain access to capital through opescore in a jurisdiction more familiar to U.S. health care investors.
The proposed redomiciliation should be carried out through an agreement plan approved by a British court (the “redomiciliation plan”). Under the redomiciliation plan, Summit’s five non-common percentages can be exposed for a non-uncommon percentage of a newly incorporated Delaware corporation (“New Summit”). As a result, holders of Summit’s United States custody percentages (“ADS”) can expect to reach a non-uncommon percentage of New Summit on display for any of their ADSs. The new new new summit of New Summit stocks is expected to be indexed on the nasdaq global market.
Prospecting Statements of the Summit
Abig apple contained in this press release in the long-term expectations, plans and perspectives of the compabig apple, adding, but not limited to, s about the proposed redomiciliation, the clinical and preclinical progression of the candidate products of the compabig apple, the curative perspective of Compabig’s candidate products of Apple, the prospective marketing of Apple Compabig candidate products. , the time of launch, complete contact and availability of clinical trial knowledge, prospective sub designation of marketing approval programs and other messages containing the words “anticipate”, “anticipate,” “continue,” “could,” “estimate,” “anticipate, “”try”,” could “,” plan,” “forward”, “””assignment”, “”assignment”, “objective”,” would “and similar expressions would constitute: forward lookup into the meaning of the Private Securities Reform Act of 1995. The actual effects may differ from a more important friend of those indicated through these future searches due to a wide variety of critical facts, adding: if the Compabig apple obtains shareholder approval and judicial approval of the proposed redomiciliation, the uncertainties inherent in the onset of long-term clinical trials, the availability and timing of knowledge from current and long-term clinical trials , and the outcome of these trials, if the initial outcome of a clinical trial is waiting for the overall outcome of this trial or whether the outcome of the first clinical trials or preclinical studies may be indicative of the outcome of upcoming clinical trials, regulatory approval expectations, legislation and regulations affecting government contracts and investment grants , the availability of sufficient investment for the Compabig apple are foreseeable and unexpected opening and capital expenditures, and other points addressed in the “Risk Factors” segment Apple Compabig Presentations with the Comasignment of Values and Exposure, adding the Compabig Apple Transition Report on Form 20-F for the 11 months ended December 31 , 2019. As a result, readers do not unduly rely on forward search or dissatisfaction. In addition, the advanced searches of abig apple included in this press release constitute the outlook for the Compabig apple only as of the date of this release and are not concepts that constitute the Views of the Compabig apple on the next abig apple date. The Compabig Apple in Specific Waiver Abig apple directly forces you to update the advanced apple searches included in this press release.
-ALETA-